Trials / Completed
CompletedNCT04862533
Effect of Beta-alanine and Pelvic Floor Muscle Training on Urinary Incontinence After Radical Prostatectomy (BELA)
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Beta-alanine and Pelvic Floor Muscle Training on Urinary Incontinence After Radical Prostatectomy (BELA)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- University Hospital Olomouc · Academic / Other
- Sex
- Male
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effectiveness of beta-alanine in combination with pelvic floor muscle training (PFMT) compared to PFMT plus placebo in men undergoing radical prostatectomy.
Detailed description
This study will assess efficacy of beta-alanine in combination with PFMT for the treatment of participants with urinary incontinence after radical prostatectomy. B-alanine is a component of L-carnosine (with L-histidine), which is needed for its synthesis. Βeta-alanine, thanks to its bioavailability) is a commonly used supplement that can improve exercise performance by increasing the amount of carnosine in striated muscle tissues. Supplementation of beta-alanine in elderly patients has resulted in an increase in physical activity, less fatigue and overall increase in L-carnosine concentration in muscles. PFMT utilization is considered a strong predictor of early return of urinary continence after radical prostatectomy (RP). We hypothesize, that combination of PFMT with beta-alanine could result in improved urinary continence after RP. The intervention will start 30 days before the surgery and will continue until primary outcome is met. Beta-alanine/placebo will be given daily. Efficacy, pharmacokinetics, biomarkers, tissue histology, participants reported outcomes and safety will be assessed. The total duration of study will be approximately 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Beta-Alanine | Participants will receive 1150mg of beta-alanine three times a day |
| DRUG | Placebo | Participants will receive matching placebo three times a day |
| PROCEDURE | Pelvic floor muscle training (PFMT) | Participants in both groups will undergo PFMT training program |
Timeline
- Start date
- 2020-02-01
- Primary completion
- 2022-08-01
- Completion
- 2022-10-01
- First posted
- 2021-04-28
- Last updated
- 2022-12-16
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT04862533. Inclusion in this directory is not an endorsement.